Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Gastrointestinal Stromal Tumors and CYP3A4[original query] |
---|
Population pharmacokinetics and pharmacogenetics of imatinib in children and adults. Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Nov 14 (21): 7102-9. Petain Aurélie, Kattygnarath Darouna, Azard Julie, Chatelut Etienne, Delbaldo Catherine, Geoerger Birgit, Barrois Michel, Séronie-Vivien Sophie, LeCesne Axel, Vassal Gilles, |
[Association between genetic polymorphisms and variation of imatinib pharmacokinetics in gastrointestinal stromal tumors]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 2017 Sep 20 (9): 1031-1034. Qiu Haibo, Zhuang Wei, Wang Xueding, Huang Min, Zhou Zhiw |
Influence of CYP2C8 polymorphisms on imatinib steady-state trough level in chronic myeloid leukemia and gastrointestinal stromal tumor patients. Pharmacogenetics and genomics 2017 06 27 (6): 223-226. Verboom Michiel C, Visser Loes, Kouwen Sander, Swen Jesse J, Diepstraten Jeroen, Posthuma Ward F, Gelderblom Hans, van Lammeren Daniëlle, Wilms Erik |
Genetic Polymorphisms and Adverse Events on Unbound Imatinib and Its Active Metabolite Concentration in Patients With Gastrointestinal Stromal Tumors. Frontiers in pharmacology 2019 10 854. Qian Yi, Sun Lu-Ning, Liu Yang-Jie, Zhang Qiang, Xu Jiang-Hao, Ma Zeng-Qing, Zhang Xue-Hui, Xu Hao, Wang Yong-Qi |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: